Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000151392 | SCV000199400 | uncertain significance | not specified | 2013-06-20 | criteria provided, single submitter | clinical testing | The p.Phe1616Leu variant in MYO15A has not been reported in individuals with hea ring loss, but has been identified in 4/65798 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs368430972) . Computational analyses (biochemical amino acid properties, conservation, Align GVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impac t to the protein. In summary, the clinical significance of this variant cannot b e determined without additional data. |
Prevention |
RCV003927459 | SCV004745375 | likely benign | MYO15A-related disorder | 2024-01-26 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Division of Human Genetics, |
RCV000477791 | SCV000536823 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 3 | 2015-11-03 | no assertion criteria provided | research |